Sign on Letter | NYS Medicaid Solvaldi Clinical Criteria Comments (Project Inform) The draft clinical criteria for the use of Sofosbuvir (Sovaldi) under NY State Medicaid is open for public comment. See the details of the comment period and clinical criteria here. Project Inform,...
Archive for category: Advocacy
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
Sign On | HAP Statement: People with Hep C Deserve Lifesaving Treatment
Advocacy, Federal Budget, Hepatitis CThis statement calls on all stakeholders to work together on a solution that ends the current practice of rationing hepatitis C treatment and sends a strong statement that all lives are worth saving.
The Council of the City of New York Proclamation Whereas: Hepatitis B is a silent epidemic that affects 1.2 million Americans, most of whom do not know they are infected with the virus. Chronic hepatitis B can damage the liver for up to 20-30 years without symptoms, and can lead ...
Sign On | Support budget for viral hepatitis programs (deadline November 22)
Advocacy, Federal BudgetHAP's ask from the Administration is for $59.8 million, which would help to sustain current programs. In addition, funding would help to fund the essential state viral hepatitis coordinator program and create a national surveillance system for viral hepatitis.
Sign On | Letter Urging HHS Secretary Sebelius to Add Hepatitis C Screening to Medicare
Advocacy, Hepatitis C, Medicare, Sign On LetterUrge HHS Secretary Sebelius to initiate a Medicare national coverage determination process for adding hepatitis C screening to Medicare.
Sign On | Ensure HCV Testing is Incorporated into Medicare Visits (Deadline April 30)
Advocacy, Federal Budget, Hepatitis C, Medicare, Sign On LetterSign the letter urging Secretary Sebelius to ensure that Medicare incorporates hepatitis C screening into the Welcome to Medicare exam and the Medicare annual wellness visit.
Urge your members of congress to sign on in support of increased funding for the Division of Viral Hepatitis at the Centers for Disease Control and Prevention (CDC) in FY2014. Members of Congress need to know that viral hepatitis is a concern in their district, that their constit...
The USPSTF's draft recommendations on testing hepatitis C among injection drug users and others at high risk is a major improvement over previous guidelines (a grade “B”, meaning testing is recommended).
The USPSTF's draft recommendations on testing hepatitis C among injection drug users and others at high risk is a major improvement over previous guidelines (a grade “B”, meaning testing is recommended). However, the Task Force failed to match the Centers for Disease Control ...
Sign On | Letter Asking USPSTF to Upgrade Baby-Boomer Testing Rating
Advocacy, Federal Policy, Hepatitis C, Sign On LetterLetter to the U.S. Preventive Services Task Force in response to its draft hepatitis C testing recommendations. NVHR encourages organizations to sign the letter below asking the USPSTF to change its “C” grade of testing Baby Boomers to a “B.”
Upcoming Events
CME | Epidemiology of Hep C (HepCure/CEI)
Hep Telehealth Workgroup
NVHR Grassroots Advocacy Monthly Call
News & Recent Posts
- Job | Hep C Harm Reduction Peer Worker (Housing Works) January 13, 2021
- NY City Council Discretionary Funding Application | Due 2/19/2021 January 13, 2021
- Research Committee Meeting Highlights | 12-16-2020 January 8, 2021
- NYC Council Viral Hepatitis Initiative January 1, 2021
- Updated Hep B Screening Recommendation (U.S. Preventive Services Task Force) December 28, 2020
- Job | Viral Hepatitis Program Medical Director @ NYC Health Dept December 21, 2020